Etzer Darout

Analyst

BMO

Analyst

Barclays

Analyst

BMO Capital Markets

Equibles does not estimate personal net worth.

About Etzer Darout

Etzer Darout is recorded as Analyst at BMO, Analyst at Barclays and Analyst at BMO Capital Markets. Etzer Darout has spoken on 3 earnings calls across 3 companies, most recently for Vir Biotechnology, Inc. on August 5, 2026. Those appearances were for Vir Biotechnology, Inc. (VIR), Jazz Pharmaceuticals plc (JAZZ) and Exelixis, Inc. (EXEL). The companies whose calls Etzer Darout spoke on are classified in the Healthcare sector.

Etzer Darout on recent calls

“Maybe just curious if you have any analogs or if you've heard any commentary from key opinion leaders on how quickly the new patient ID and diagnosis methods could be adopted by physicians for HTV, and then question on the expenses in the second quarter, and whether or not you can maybe comment on what you see sort of…”

Analyst — Barclays, Vir Biotechnology Second Quarter 2026 Corporate Update and Financial Results Conference Call · August 5, 2026

“Just a follow-up on comments on ZyWave and guidance from Phil earlier.”

Analyst — Barclays, Q2 2026 Jazz Pharmaceuticals Earnings Conference Call · August 3, 2026

“First, could you speak to the balance of the R&D spend step-up in the full year guidance beyond the funds you indicated for the two deals announced today? Second, the early data for CBX-12 was interesting.”

Analyst — BMO, Exelixis, Inc. Q3 FY2022 Earnings Call · November 1, 2022